Hence, we speculated the BNIP3-AMPK-ENO2 crosstalk exists and may function as the regulator of glycolytic metabolism and promoter of competitive advantage phenotypes of lenvatinib-resistant HCC cells in cell competition scenario. Here, BNIP3 is linked to hepatocellular carcinoma.